Commerce and Industry Minister Piyush Goyal has said that India is prepared to provide market access to high-quality and innovative pharmaceutical products from partner countries as India secured preferential market access, including zero-duty access for several pharmaceutical products, through its free trade agreements (FTAs). He noted that the Indian pharmaceuticals industry, currently valued at around $60 billion, has the potential to double in size over the next five years.
The minister invited global pharmaceutical companies to partner with India in its journey towards innovation-led and inclusive healthcare. He added that India is looking to move beyond generics into innovation-driven pharmaceutical products while continuing to provide affordable medicines to patients across the world.
Emphasising the importance of India's generic pharmaceutical industry, he said millions of patients worldwide benefit from affordable medicines supplied by India. He noted that while generic medicines account for 80-90 per cent of the volume of medicines sold in the United States, they represent only about 10-15 per cent of the value, underlining the affordability and societal value of generic medicines.
Further, he stated that around 65-70 per cent of World Health Organization vaccine requirements are sourced from India and that 10 of the world's 25 largest generic pharmaceutical companies operate from India. He added that India has the highest number of US FDA-approved pharmaceutical manufacturing plants outside the United States.
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: